Symphony Environmental Technologies (AIM: SYM ) said test reports have proven that its antiviral nitrile gloves and polypropylene fabric face masks can protect against COVID-19.
The plastic technology specialist said it had received further successful test reports from the Laboratory of Virology at the University of Campinas, Brazil in regard to the gloves and facemask which are both made using Symphony's d2pAM (antimicrobial) technology.
The company outlined to investors that both items were tested in accordance with ISO 21702-2019, the international standard for the measurement of antiviral activity on plastics and other non-porous surfaces, against the Coronavirus strain MHV, genus Betacoronavirus.
Following this, the successful test reports concluded that "we recommend using d2pAM as a potential virucidal agent for the Coronavirus group and helps in controlling COVID-19."
The glove showed a 99.99% virus-reduction after one hour of contact while the facemask showed a 99% virus-reduction after one hour with the facemask, and 99.9% after two hours.
Shares in Symphony Environmental Technologies have doubled since the beginning of July 2020 to open 19.05% higher this morning at 25p following the announcement.
The same tests were performed on a glove and a facemask which did not contain Symphony’s d2pAM technology, and concluded that no virucidal effect was detected.
Symphony's Chief Executive, Michael Laurier, said the results are “a significant step forward” in its global marketing campaign to promote the importance of d2p technology in essential products. He said he believes this signifies “a major breakthrough” in the fight against COVID.
He added, “These masks and gloves will provide essential additional protection for everyone, especially for staff, patients, and visitors in a hospital or care-home environment.”
The group said the masks are already available in commercial volumes and, subject to securing manufacturing space, it hopes to be able to supply the gloves during the second quarter of 2021 and will market both products through its global distribution network.
“We are extremely pleased with this latest scientific validation of our d2pAM technology, but it is currently too early to estimate the level of demand for these products,” added Laurier.
Eurofins Laboratories and Univcamp proved antiviral efficacy on polyethylene film made with Symphony's d2pAM technology back in August and September 2020, respectively.
Follow News & Updates from Symphony Environmental Technologies here: